Active 0 6 0 6 O
viral 7 12 7 12 B-chronic_disease
, 12 13 12 13 O
bacterial 14 23 14 23 B-chronic_disease
, 23 24 23 24 O
or 25 27 25 27 O
systemic 28 36 28 36 B-chronic_disease
fungal 37 43 37 43 I-chronic_disease
infection 44 53 44 53 I-chronic_disease
requiring 54 63 54 63 O
parenteral 64 74 64 74 B-treatment
treatment 75 84 75 84 I-treatment
within 85 91 85 91 O
7 92 93 92 93 B-upper_bound
days 94 98 94 98 I-upper_bound
of 99 101 99 101 O
first 102 107 102 107 O
study 108 113 108 113 O
drug 114 118 114 118 O
administration 119 133 119 133 O

Clinically 0 10 134 144 O
significant 11 22 145 156 O
pulmonary 23 32 157 166 O
compromise 33 43 167 177 O
within 44 50 178 184 O
28 51 53 185 187 B-upper_bound
days 54 58 188 192 I-upper_bound
of 59 61 193 195 O
first 62 67 196 201 O
dose 68 72 202 206 O
, 72 73 206 207 O
including 74 83 208 217 O
pneumonia 84 93 218 227 B-chronic_disease
, 93 94 227 228 O
pneumonitis 95 106 229 240 B-chronic_disease
, 106 107 240 241 O
requirement 108 119 242 253 O
for 120 123 254 257 O
supplemental 124 136 258 270 O
oxygen 137 143 271 277 O
) 143 144 277 278 O
. 144 145 278 279 O
use 146 149 280 283 O
to 150 152 284 286 O
maintain 153 161 287 295 O
adequate 162 170 296 304 O
oxygenation 171 182 305 316 O
, 182 183 316 317 O
or 184 186 318 320 O
pleural 187 194 321 328 B-chronic_disease
effusion 195 203 329 337 I-chronic_disease
sufficient 204 214 338 348 O
to 215 217 349 351 O
warrant 218 225 352 359 O
pleurocentesis 226 240 360 374 B-treatment
or 241 243 375 377 O
any 244 247 378 381 O
history 248 255 382 389 O
of 256 258 390 392 O
â‰¥ 259 260 393 394 O
Grade 261 266 395 400 B-lower_bound
3 267 268 401 402 I-lower_bound
drug 269 273 403 407 O
induced 274 281 408 415 O
or 282 284 416 418 O
radiation 285 294 419 428 B-chronic_disease
pneumonitis 295 306 429 440 I-chronic_disease

Dose 0 4 441 445 O
escalation 5 15 446 456 O
phase 16 21 457 462 O
prior 22 27 463 468 B-treatment
systemic 28 36 469 477 I-treatment
treatment 37 46 478 487 I-treatment
requirements 47 59 488 500 O

Easter 0 6 501 507 B-clinical_variable
Cooperative 7 18 508 519 I-clinical_variable
Oncology 19 27 520 528 I-clinical_variable
Group 28 33 529 534 I-clinical_variable
( 34 35 535 536 I-clinical_variable
ECOG 35 39 536 540 I-clinical_variable
) 39 40 540 541 I-clinical_variable
performance 41 52 542 553 I-clinical_variable
status 53 59 554 560 I-clinical_variable
0 60 61 561 562 B-lower_bound
or 62 64 563 565 O
1 65 66 566 567 B-upper_bound

GI 0 2 568 570 B-chronic_disease
bleeding 3 11 571 579 I-chronic_disease
or 12 14 580 582 O
acute 15 20 583 588 B-chronic_disease
pancreatitis 21 33 589 601 I-chronic_disease
within 34 40 602 608 O
3 41 42 609 610 B-upper_bound
months 43 49 611 617 I-upper_bound

GI 0 2 618 620 B-chronic_disease
perforation 3 14 621 632 I-chronic_disease
within 15 21 633 639 O
1 22 23 640 641 B-upper_bound
year 24 28 642 646 I-upper_bound

Histologically 0 14 647 661 O
and/or 15 21 662 668 O
cytologically 22 35 669 682 O
proven 36 42 683 689 O
unresectable 43 55 690 702 O
locally 56 63 703 710 O
advanced 64 72 711 719 O
or 73 75 720 722 O
metastatic 76 86 723 733 B-cancer
tumors 87 93 734 740 I-cancer
that 94 98 741 745 O
express 99 106 746 753 O
B7 107 109 754 756 O
- 109 110 756 757 O
H3 110 112 757 759 O
on 113 115 760 762 O
the 116 119 763 766 O
membrane 120 128 767 775 O
or 129 131 776 778 O
vasculature 132 143 779 790 O

History 0 7 791 798 O
of 8 10 799 801 O
clinically 11 21 802 812 O
- 21 22 812 813 O
significant 22 33 813 824 O
gastrointestinal 34 50 825 841 B-chronic_disease
( 51 52 842 843 I-chronic_disease
GI 52 54 843 845 I-chronic_disease
) 54 55 845 846 I-chronic_disease
disease 56 63 847 854 I-chronic_disease

Known 0 5 855 860 O
history 6 13 861 868 O
of 14 16 869 871 O
hepatitis 17 26 872 881 B-chronic_disease
B 27 28 882 883 I-chronic_disease
or 29 31 884 886 I-chronic_disease
C 32 33 887 888 I-chronic_disease
infection 34 43 889 898 I-chronic_disease
or 44 46 899 901 O
known 47 52 902 907 O
positive 53 61 908 916 O
test 62 66 917 921 O
for 67 70 922 925 O
hepatitis 71 80 926 935 B-chronic_disease
B 81 82 936 937 I-chronic_disease
surface 83 90 938 945 I-chronic_disease
antigen 91 98 946 953 I-chronic_disease
or 99 101 954 956 I-chronic_disease
core 102 106 957 961 I-chronic_disease
antigen 107 114 962 969 I-chronic_disease
, 114 115 969 970 O
or 116 118 971 973 O
hepatitis 119 128 974 983 B-chronic_disease
C 129 130 984 985 I-chronic_disease
polymerase 131 141 986 996 O
chain 142 147 997 1002 O
reaction 148 156 1003 1011 O
( 157 158 1012 1013 O
PCR 158 161 1013 1016 O
) 161 162 1016 1017 O

Known 0 5 1018 1023 O
hypersensitivity 6 22 1024 1040 O
to 23 25 1041 1043 O
recombinant 26 37 1044 1055 B-allergy_name
proteins 38 46 1056 1064 I-allergy_name
, 46 47 1064 1065 O
polysorbate 48 59 1066 1077 B-allergy_name
80 60 62 1078 1080 I-allergy_name
, 62 63 1080 1081 O
or 64 66 1082 1084 O
any 67 70 1085 1088 O
excipient 71 80 1089 1098 O
contained 81 90 1099 1108 O
in 91 93 1109 1111 O
the 94 97 1112 1115 O
drug 98 102 1116 1120 O
or 103 105 1121 1123 O
vehicle 106 113 1124 1131 O
formulation 114 125 1132 1143 O
for 126 129 1144 1147 O
MGD009 130 136 1148 1154 O

Patients 0 8 1155 1163 O
with 9 13 1164 1168 O
prior 14 19 1169 1174 O
immune 20 26 1175 1181 O
checkpoint 27 37 1182 1192 B-treatment
inhibitors 38 48 1193 1203 I-treatment
must 49 53 1204 1208 O
have 54 58 1209 1213 O
related 59 66 1214 1221 O
toxicities 67 77 1222 1232 O
reduced 78 85 1233 1240 O
to 86 88 1241 1243 O
Grade 89 94 1244 1249 O
0 95 96 1250 1251 O
, 96 97 1251 1252 O
1 98 99 1253 1254 O
, 99 100 1254 1255 O
or 101 103 1256 1258 O
baseline 104 112 1259 1267 O

The 0 3 1268 1271 O
requirement 4 15 1272 1283 O
for 16 19 1284 1287 O
previous 20 28 1288 1296 B-treatment
systemic 29 37 1297 1305 I-treatment
therapy 38 45 1306 1313 I-treatment
may 46 49 1314 1317 O
be 50 52 1318 1320 O
waived 53 59 1321 1327 O
if 60 62 1328 1330 O
a 63 64 1331 1332 O
person 65 71 1333 1339 O
was 72 75 1340 1343 O
intolerant 76 86 1344 1354 O
of 87 89 1355 1357 O
standard 90 98 1358 1366 B-treatment
front 99 104 1367 1372 I-treatment
- 104 105 1372 1373 I-treatment
line 105 109 1373 1377 I-treatment
therapy 110 117 1378 1385 I-treatment

colon 0 5 1386 1391 B-cancer
cancer 6 12 1392 1398 I-cancer
: 12 13 1398 1399 O
2 14 15 1400 1401 B-lower_bound
- 15 16 1401 1402 O
4 16 17 1402 1403 B-upper_bound
prior 18 23 1404 1409 B-treatment
treatments 24 34 1410 1420 I-treatment

cutaneous 0 9 1421 1430 B-cancer
melanoma 10 18 1431 1439 I-cancer
: 18 19 1439 1440 O
at 20 22 1441 1443 O
least 23 28 1444 1449 O
1 29 30 1450 1451 B-lower_bound
prior 31 36 1452 1457 B-treatment
treatment 37 46 1458 1467 I-treatment
( 47 48 1468 1469 O
including 48 57 1469 1478 O
immunotherapy 58 71 1479 1492 B-treatment
) 71 72 1492 1493 O

diverticulitis 0 14 1494 1508 B-chronic_disease
within 15 21 1509 1515 O
4 22 23 1516 1517 B-upper_bound
weeks 24 29 1518 1523 I-upper_bound
of 30 32 1524 1526 O
first 33 38 1527 1532 O
study 39 44 1533 1538 O
drug 45 49 1539 1543 O
administration 50 64 1544 1558 O

ovarian 0 7 1559 1566 B-cancer
cancer 8 14 1567 1573 I-cancer
: 14 15 1573 1574 O
2 16 17 1575 1576 B-lower_bound
- 17 18 1576 1577 O
4 18 19 1577 1578 B-upper_bound
prior 20 25 1579 1584 O
treatments 26 36 1585 1595 B-treatment

pleural 0 7 1596 1603 B-cancer
mesothelioma 8 20 1604 1616 I-cancer
, 20 21 1616 1617 O
pancreatic 22 32 1618 1628 B-cancer
cancer 33 39 1629 1635 I-cancer
: 39 40 1635 1636 O
1 41 42 1637 1638 B-lower_bound
- 42 43 1638 1639 O
3 43 44 1639 1640 B-upper_bound
prior 45 50 1641 1646 B-treatment
treatments 51 61 1647 1657 I-treatment

radiation 0 9 1658 1667 B-treatment
within 10 16 1668 1674 O
2 17 18 1675 1676 B-upper_bound
weeks 19 24 1677 1682 I-upper_bound

